Abstract CT213: Anlotinib Plus Chemotherapy As First-Line Therapy for Gastrointestinal Tumor Patients with Unresectable Liver Metastasis: Updated Results from a Multi-Cohort, Multi-Center Phase II Trial ALTER-G-001-cohort C
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要